SlideShare una empresa de Scribd logo
1 de 47
PSORIASIS
ETIOPATOGENESIS AND PHARMACOTHERAPY

BY
VINEETHA B MENON
PHARM.D (PB)
FIRST YEAR
JSS COLLEGE OF PHARMACY,
MYSORE

Feb 1, 2014

1
CONTENTS
 INTRODUCTION
 EPIDEMIOLOGY
 AETIOLOGY
 PATHOGENESIS
 DIAGNOSIS
 CLINICAL FEATURES
 TREATMENT
Feb 1, 2014

2
INTRODUCTION
• Psoriasis is a chronic inflammatory
condition that may affect the skin and
joints

Feb 1, 2014

3
• EPIDEMIOLOGY

Feb 1, 2014

4
EPIDEMIOLOGY
• Psoriasis affects both sexes equally

• Can occur at any age, although it most
commonly appears for the first time
between the ages of 15 and 25 years

Feb 1, 2014

5
• AETIOLOGY

Feb 1, 2014

6
AETIOLOGY

Feb 1, 2014

7
• PATHOGENESIS

Feb 1, 2014

8
PATHOGENESIS
•Many changes
occur in the skin
•Epidermis –
Acanthosis,
Parakeratosis
•Dermis –
capillaries are
dilated, twisted,
closer to the
surface of the skin
Feb 1, 2014

9
• Large number of inflammatory cells are
present in all layers of the skingranulocytes are predominant and form
micro-abscessess in the epidermis
• Langerhan cells and lymphocytes are also
increased
• Main abnormality is
epidermal cell turn over

Feb 1, 2014

the

increased

10
Two hypothesis:
1. Hyperproliferation may be due to
immunological response. Cytokines
released by lymphocytes and langerhan
cells may further stimulate the
inflammatory
cells
which
cause
epidermal cell turn over at an increased
rate

Feb 1, 2014

11
2. Epithelial cells themselves produce
cytokines which promote proliferation
of
epithelial
cells
and
attract
lymphocytes

Feb 1, 2014

12
• DIAGNOSIS

Feb 1, 2014

13
DIAGNOSIS
• A diagnosis of psoriasis is usually based on the
appearance of the skin
• There are no special blood tests or diagnostic
procedures
• Skin biopsy, may be needed to rule out other
disorders and to confirm the diagnosis
• Skin from a biopsy will show clubbed rete pegs, if
positive for psoriasis
• Another sign of psoriasis is that when the plaques
are scraped, one can see pinpoint bleeding from
the skin below 
Feb 1, 2014

14
Rete pegs are
the
epithelial
extensions that
project into the
underlying
connective tissue

Feb 1, 2014

15
• CLINICAL FEATURES

Feb 1, 2014

16
CLINICAL FEATURES
• Typical psoriatic lesion
is red, scaly, sharply
demarcated plaque

Feb 1, 2014

17
• It can be on any
size and can affect
any part of the
body

Feb 1, 2014

18
• The scales are silvery and easily scraped
off revealing tiny bleed points

• Psoriasis is not typically itchy, but it can
cause itching when severely inflammed
and rapidly spreading to the palms and
soles
Feb 1, 2014

19
• Different patterns of psoriasis are:
1.
2.
3.
4.
5.
6.
7.

Guttate psoriasis
Chronic plaque psoriasis
Psoriasis of scalp
Psoriasis of nails
Psoriasis of palms and soles
Flexural psoriasis
Erythrodermic and generalized pustular
psoriasis
8. Psoriatic arthropathy

Feb 1, 2014

20
GUTTATE
PSORIASIS
Multiple small plaques are
seen all over the body
Mainly seen in children
after streptococcal sore
throat
Self limiting after a few
weeks

Feb 1, 2014

21
CHRONIC PLAQUE
PSORIASIS
Medium and large plaques
occur on the limb and trunk
Very persistent

Feb 1, 2014

22
PSORIASIS OF THE
SCALP
May occur as demarcated
plaques or may involve the
entire scalp extending to the
hairline
Scales are white, thick and
chalky
Hair loss will occur if the
scalp is thickly scaled
Recover if the scales are
cleared and kept under
control
Feb 1, 2014

23
PSORIASIS OF THE
NAILS
Pitting, onycholysis and
hyperkeratosis under the
nail
Very resistant

Feb 1, 2014

24
PSORIASIS OF THE
PALMS AN SOLES
Sharp demarcation of the
involved areas
Affected areas are inflammed
and scaly and may contain
sterile pustules of large pin
head size. These pustules dry
up and form brown macules
Affected skin becomes
hyperatotic and fissuring
Secondary infection with
itching and pain are common
Feb 1, 2014

25
FLEXURAL PSORIASIS
Psoriasis occurs in the axillae,
submammary areas, groin and
genitalia
Demarcation is present, but
the affected areas are glazy
rather than scaly and is bright
red in color

Feb 1, 2014

26
ERYTHRODERMIC AND
GENERALIZED
PUSTULAR PSORIASIS
Severe and life threatening condition
Uncommon
Whole skin surface is involved and
highly inflammed and the patient is
sick
Pustules are sterile and coalesce to
form sheets of pus

Feb 1, 2014

27
PSORIATIC
ARTHROPATHY

Occurs in 5% of the patients with
psoriasis
Similar to RA, but RF is negative
Different patterns:
1.
2.
3.

Feb 1, 2014

Distal Arthritis
Large Joint Involvement
Spodilitis/ Sacroiliitis

28
• TREATMENT

Feb 1, 2014

29
TREATMENT

Aimed at controlling the current attack and not curing,
and does not influence future progress of the disease
TOPICAL THERAPY
1. Emolients
2. Topical Steroids
3. Dithranol
4. Coal Tar
5. Salicylic Acid
6. Vitamin D Analogues
7. UVB
Feb 1, 2014

SYSTEMIC THERAPY
1. PUVA
2. Cytotoxic Drugs
3. Immunosuppressant
Drugs
4. Acitretin
5. Photodynamic Therapy
6. Systemic Steroids
30
TOPICAL THERAPY
1. EMOLIENTS
•

Used alone in very mild cases

•

Used along with other therapies for moderate to
severe disease

Feb 1, 2014

31
2. TOPICAL STEROIDS
•

Most useful for acutely inflammed psoriasis

•

Mild steroids are used on face and flexures

•

Potent

steroids

are

used on hands

and

feet; in

combination with Clioquinol or Salicylic acid
•

Aq. and alcoholic solutions cause stinging and burning,
thus usually ointments, creams and mousse are prefered

•

Use of potent steroids on large areas of psoriasis may
cause rebound flare when discontinued

Feb 1, 2014

32
Feb 1, 2014

33
4. COAL TAR
• Used in combination with emolients, topical steroids,
and salicylic acid
• Used for guttate psoriasis, psoriasis of the scalp, and
localized pustular psoriasis of the palms and soles
• Efficiency of coal tar is enhanced when used with
UVB

Feb 1, 2014

34
5. SALICYLIC ACID

• Useful to remove the scales
• Used in preparation for other treatment

Feb 1, 2014

35
6. VITAMIN D ANALOGUES
• Efficacy of topical vit D analogues is enhanced when
used in combination with topical steroids and UVB
• Calciptriol & Tacalcitol
• Calciptriol is more effective than coal tar and
dithranol. It cannot be used on face.
• Tacalcitol is used for once daily treatment of chronic
plaque psoriasis. It can be used on the face
Feb 1, 2014

36
7. UVB
• Short

wavelength

ultraviolet

light

is

used

in

combination with coal tar or dithranol

• Narrow band UVB is more effective

Feb 1, 2014

37
SYSTEMIC THERAPY
1. PUVA
•

Used for the treatment of moderate to severe chronic
plaque psoriasis

•

PSORALENS: drugs that are activated by UVA (320400nm), to interfere with the DNA synthesis and reduce
the epidermal cell turn over

•

Eg: 5-methoxy psoralen & 8-methoxy psoralen

•

Can be administered orally or it can be applied topically

Feb 1, 2014

38
The time of exposure is calculated
based upon the previous light
testing and the time interval is
increased if tolerated by the patient
as the treatment progresses
Treatment is given twice weekly for
6 weeks
Unless the disease is severe,
maintenance dose is avoided to
minimize the long term side effects
Adverse effects: Nausea, pruritis,
dry skin, aging of the skin,
melanoma and non-melanoma skin
cancer
Feb 1, 2014

39
2. CYTOTOXIC DRUGS
•

Methotrexate & hydroxycarbamide

• METHOTREXATE
•

Most effective in the treatment of psoriatic arthritis

•

Test dose- 2.5 mg

•

Then 30 mg weekly

•

Side effects: nausea, fatigue, GI bleeding

Feb 1, 2014

40
• HYDROXYCARBAMIDE
• It should be used continuously as relapse will
occur when the drug is stopped
• Causes bone marrow depression

Feb 1, 2014

41
3. IMMUNOSUPPRESSANT DRUGS
• CICLOSPORIN
•

Severe psoriasis

•

Dose is 2-5 mg/kg/day

•

Relapse may occur when the drug is stopped but
intermittent therapy is preferred to maintenance
therapy

•

Avoid sun over exposure, PUVA & UVB therapy

Feb 1, 2014

42
4. ACITRETIN

•

Used for severe resistant psoriasis, acute pustular
psoriasis, and palmoplantar psoriasis

•

Has teratogenic effect

•

Re-PUVA therapy: acitretin + PUVA

•

It causes bone maturation abnormality, LFT and
serum lipid levels

•

Causes dry skin and hair loss

Feb 1, 2014

43
5. PHOTODYNAMIC THERAPY
•

5-aminolaevullinic acid (ALA) causes local
accumulation of proto porphyrin 9 which is activated
by irradiation with visible light and causes tissue
destruction

•

Used for localized plaque psoriasis

•

Causes burning sensation at the site of treatment

Feb 1, 2014

44
6. SYSTEMIC STEROIDS

• Not commonly used
• May be used for the management of life threatening
erythroderma
• Systemic steroids or their withdrawal may itself
provoke acute generalised pustular psoriasis

Feb 1, 2014

45
Feb 1, 2014

46
THANK
YOU

Feb 1, 2014

47

Más contenido relacionado

La actualidad más candente (20)

Eczema
EczemaEczema
Eczema
 
Fungal infections of skin [compatibility mode]
Fungal infections of skin [compatibility mode]Fungal infections of skin [compatibility mode]
Fungal infections of skin [compatibility mode]
 
Cyclosporine in dermatology
Cyclosporine in dermatologyCyclosporine in dermatology
Cyclosporine in dermatology
 
Psoriasis-The best Presentation
Psoriasis-The best PresentationPsoriasis-The best Presentation
Psoriasis-The best Presentation
 
Eczema
EczemaEczema
Eczema
 
Psoriasis
PsoriasisPsoriasis
Psoriasis
 
Presentation eczema
Presentation eczemaPresentation eczema
Presentation eczema
 
Pruritis or itching
Pruritis or itchingPruritis or itching
Pruritis or itching
 
Methotrexate 2.pptx
Methotrexate 2.pptxMethotrexate 2.pptx
Methotrexate 2.pptx
 
Eczema
EczemaEczema
Eczema
 
Psoriasis - A BRIEF OUTLOOK..................................by Vishnu R.Nair...
Psoriasis - A BRIEF OUTLOOK..................................by Vishnu R.Nair...Psoriasis - A BRIEF OUTLOOK..................................by Vishnu R.Nair...
Psoriasis - A BRIEF OUTLOOK..................................by Vishnu R.Nair...
 
Nutrophilic dermatosis
Nutrophilic dermatosisNutrophilic dermatosis
Nutrophilic dermatosis
 
Impetigo
Impetigo Impetigo
Impetigo
 
Skin fungal infection
Skin fungal infectionSkin fungal infection
Skin fungal infection
 
Psoriasis
Psoriasis Psoriasis
Psoriasis
 
Dapsone, colchicine
Dapsone, colchicineDapsone, colchicine
Dapsone, colchicine
 
Eczema by Manaswi
Eczema by ManaswiEczema by Manaswi
Eczema by Manaswi
 
Impetigo
ImpetigoImpetigo
Impetigo
 
Rheumatoid arthritis and management
Rheumatoid arthritis and managementRheumatoid arthritis and management
Rheumatoid arthritis and management
 
Dermatology pharmacology
Dermatology pharmacologyDermatology pharmacology
Dermatology pharmacology
 

Destacado (11)

Osteoporosis
OsteoporosisOsteoporosis
Osteoporosis
 
Osteoporosis, Diagnosis and treatment
Osteoporosis, Diagnosis and treatmentOsteoporosis, Diagnosis and treatment
Osteoporosis, Diagnosis and treatment
 
Post menopausal osteoporosis
Post menopausal osteoporosisPost menopausal osteoporosis
Post menopausal osteoporosis
 
Pharmacotherapy of osteoporosis
Pharmacotherapy of osteoporosisPharmacotherapy of osteoporosis
Pharmacotherapy of osteoporosis
 
Psoriasis
PsoriasisPsoriasis
Psoriasis
 
Salivary glands
Salivary glandsSalivary glands
Salivary glands
 
Connective tissue
Connective tissueConnective tissue
Connective tissue
 
Connective tissue slides
Connective tissue slidesConnective tissue slides
Connective tissue slides
 
Histological techniques for life science researchers
Histological techniques for life science researchersHistological techniques for life science researchers
Histological techniques for life science researchers
 
Salivary gland histology
Salivary gland histologySalivary gland histology
Salivary gland histology
 
Connective tissue.pptx
Connective tissue.pptxConnective tissue.pptx
Connective tissue.pptx
 

Similar a Psoriasis

Psoriasis (dermatology)
Psoriasis (dermatology)Psoriasis (dermatology)
Psoriasis (dermatology)D.A.B.M
 
Psoriasis uzysuhsh sud. Hdusbbsjhsbejbs s. S u sjns shusiw
Psoriasis uzysuhsh sud. Hdusbbsjhsbejbs s.  S u sjns shusiwPsoriasis uzysuhsh sud. Hdusbbsjhsbejbs s.  S u sjns shusiw
Psoriasis uzysuhsh sud. Hdusbbsjhsbejbs s. S u sjns shusiwssusere3aa49
 
Psoriasis management in the community
Psoriasis management in the communityPsoriasis management in the community
Psoriasis management in the communityusman buhari
 
7 (245-345pm) - Eczema talk APP CME 2019_Robyn Morrissette_09 24 19.ppt
7 (245-345pm) - Eczema talk APP CME 2019_Robyn Morrissette_09 24 19.ppt7 (245-345pm) - Eczema talk APP CME 2019_Robyn Morrissette_09 24 19.ppt
7 (245-345pm) - Eczema talk APP CME 2019_Robyn Morrissette_09 24 19.pptWolfram Bodenmüller
 
7 (245-345pm) - Eczema talk APP CME 2019_Robyn Morrissette_09 24 19.ppt
7 (245-345pm) - Eczema talk APP CME 2019_Robyn Morrissette_09 24 19.ppt7 (245-345pm) - Eczema talk APP CME 2019_Robyn Morrissette_09 24 19.ppt
7 (245-345pm) - Eczema talk APP CME 2019_Robyn Morrissette_09 24 19.pptssuser8705f6
 
Dermatology.-WPS Office.pptx
Dermatology.-WPS Office.pptxDermatology.-WPS Office.pptx
Dermatology.-WPS Office.pptxSudipta Roy
 
Psoriasis-all that you need to know
Psoriasis-all that you need to knowPsoriasis-all that you need to know
Psoriasis-all that you need to knowShailvi Banka
 
psoriasis-160310171501.pdf
psoriasis-160310171501.pdfpsoriasis-160310171501.pdf
psoriasis-160310171501.pdfdhanu gaysonsiri
 
Management of exfoliative dermatitis.pptx
Management of exfoliative dermatitis.pptxManagement of exfoliative dermatitis.pptx
Management of exfoliative dermatitis.pptxKemi Adaramola
 
psoriasis-160716060900.pdf
psoriasis-160716060900.pdfpsoriasis-160716060900.pdf
psoriasis-160716060900.pdfShaliniN51
 
Psoriasis (Dermatological diseases) pptx
Psoriasis (Dermatological diseases) pptxPsoriasis (Dermatological diseases) pptx
Psoriasis (Dermatological diseases) pptxAman Kumar
 
chemical injuries to orofacial structures
chemical injuries to orofacial structureschemical injuries to orofacial structures
chemical injuries to orofacial structuresdhanesh narayanan
 

Similar a Psoriasis (20)

Psoriasis (dermatology)
Psoriasis (dermatology)Psoriasis (dermatology)
Psoriasis (dermatology)
 
Role of the specialist nurse
Role of the specialist nurseRole of the specialist nurse
Role of the specialist nurse
 
Psoriasis uzysuhsh sud. Hdusbbsjhsbejbs s. S u sjns shusiw
Psoriasis uzysuhsh sud. Hdusbbsjhsbejbs s.  S u sjns shusiwPsoriasis uzysuhsh sud. Hdusbbsjhsbejbs s.  S u sjns shusiw
Psoriasis uzysuhsh sud. Hdusbbsjhsbejbs s. S u sjns shusiw
 
Psoriasis management in the community
Psoriasis management in the communityPsoriasis management in the community
Psoriasis management in the community
 
7 (245-345pm) - Eczema talk APP CME 2019_Robyn Morrissette_09 24 19.ppt
7 (245-345pm) - Eczema talk APP CME 2019_Robyn Morrissette_09 24 19.ppt7 (245-345pm) - Eczema talk APP CME 2019_Robyn Morrissette_09 24 19.ppt
7 (245-345pm) - Eczema talk APP CME 2019_Robyn Morrissette_09 24 19.ppt
 
7 (245-345pm) - Eczema talk APP CME 2019_Robyn Morrissette_09 24 19.ppt
7 (245-345pm) - Eczema talk APP CME 2019_Robyn Morrissette_09 24 19.ppt7 (245-345pm) - Eczema talk APP CME 2019_Robyn Morrissette_09 24 19.ppt
7 (245-345pm) - Eczema talk APP CME 2019_Robyn Morrissette_09 24 19.ppt
 
Psoriasis
PsoriasisPsoriasis
Psoriasis
 
Dermatology.-WPS Office.pptx
Dermatology.-WPS Office.pptxDermatology.-WPS Office.pptx
Dermatology.-WPS Office.pptx
 
psoriasis
 psoriasis psoriasis
psoriasis
 
Psoriasis-all that you need to know
Psoriasis-all that you need to knowPsoriasis-all that you need to know
Psoriasis-all that you need to know
 
Psoriasis
PsoriasisPsoriasis
Psoriasis
 
psoriasis-160310171501.pdf
psoriasis-160310171501.pdfpsoriasis-160310171501.pdf
psoriasis-160310171501.pdf
 
Management of exfoliative dermatitis.pptx
Management of exfoliative dermatitis.pptxManagement of exfoliative dermatitis.pptx
Management of exfoliative dermatitis.pptx
 
psoriasis-160716060900.pdf
psoriasis-160716060900.pdfpsoriasis-160716060900.pdf
psoriasis-160716060900.pdf
 
Psoriasis
PsoriasisPsoriasis
Psoriasis
 
Psoriasis (Dermatological diseases) pptx
Psoriasis (Dermatological diseases) pptxPsoriasis (Dermatological diseases) pptx
Psoriasis (Dermatological diseases) pptx
 
Psoriasis.pdf
Psoriasis.pdfPsoriasis.pdf
Psoriasis.pdf
 
Rosacea tutorial.pptx
Rosacea tutorial.pptxRosacea tutorial.pptx
Rosacea tutorial.pptx
 
Rosacea tutorial.pptx
Rosacea tutorial.pptxRosacea tutorial.pptx
Rosacea tutorial.pptx
 
chemical injuries to orofacial structures
chemical injuries to orofacial structureschemical injuries to orofacial structures
chemical injuries to orofacial structures
 

Más de Vineetha Menon

Spondylolisthesis with gross osteoporosis
Spondylolisthesis with gross osteoporosisSpondylolisthesis with gross osteoporosis
Spondylolisthesis with gross osteoporosisVineetha Menon
 
Management of lactic acidosis
Management of lactic acidosisManagement of lactic acidosis
Management of lactic acidosisVineetha Menon
 
Genetic polymorphism in drug transport
Genetic polymorphism in drug transportGenetic polymorphism in drug transport
Genetic polymorphism in drug transportVineetha Menon
 
Analysis of kinetic data
Analysis of kinetic dataAnalysis of kinetic data
Analysis of kinetic dataVineetha Menon
 
Case on type II diabetes mellitus with peripheral neuropathy with hypertension
Case on type II diabetes mellitus with peripheral neuropathy with hypertensionCase on type II diabetes mellitus with peripheral neuropathy with hypertension
Case on type II diabetes mellitus with peripheral neuropathy with hypertensionVineetha Menon
 
Prescription event monitoring and record linkage system
Prescription event monitoring and record linkage systemPrescription event monitoring and record linkage system
Prescription event monitoring and record linkage systemVineetha Menon
 

Más de Vineetha Menon (8)

Spondylolisthesis with gross osteoporosis
Spondylolisthesis with gross osteoporosisSpondylolisthesis with gross osteoporosis
Spondylolisthesis with gross osteoporosis
 
Management of lactic acidosis
Management of lactic acidosisManagement of lactic acidosis
Management of lactic acidosis
 
Genetic polymorphism in drug transport
Genetic polymorphism in drug transportGenetic polymorphism in drug transport
Genetic polymorphism in drug transport
 
Tdm technologies
Tdm technologiesTdm technologies
Tdm technologies
 
Analysis of kinetic data
Analysis of kinetic dataAnalysis of kinetic data
Analysis of kinetic data
 
Case on type II diabetes mellitus with peripheral neuropathy with hypertension
Case on type II diabetes mellitus with peripheral neuropathy with hypertensionCase on type II diabetes mellitus with peripheral neuropathy with hypertension
Case on type II diabetes mellitus with peripheral neuropathy with hypertension
 
Prescription event monitoring and record linkage system
Prescription event monitoring and record linkage systemPrescription event monitoring and record linkage system
Prescription event monitoring and record linkage system
 
Seizure Disorder
Seizure DisorderSeizure Disorder
Seizure Disorder
 

Último

PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxPERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxdrashraf369
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfSreeja Cherukuru
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptkedirjemalharun
 
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxPresentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxpdamico1
 
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfSGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfHongBiThi1
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiGoogle
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxSasikiranMarri
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Prerana Jadhav
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...sdateam0
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdfDolisha Warbi
 
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsMedicoseAcademics
 
maternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortalitymaternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortalityhardikdabas3
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdfDolisha Warbi
 
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-KnowledgeGiftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-Knowledgeassessoriafabianodea
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxdrashraf369
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptxBibekananda shah
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxDr. Dheeraj Kumar
 
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfPULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfDolisha Warbi
 
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...MehranMouzam
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Badalona Serveis Assistencials
 

Último (20)

PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxPERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.ppt
 
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxPresentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
 
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfSGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali Rai
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptx
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
 
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes Functions
 
maternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortalitymaternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortality
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
 
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-KnowledgeGiftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptx
 
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfPULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
 
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
 

Psoriasis

  • 1. PSORIASIS ETIOPATOGENESIS AND PHARMACOTHERAPY BY VINEETHA B MENON PHARM.D (PB) FIRST YEAR JSS COLLEGE OF PHARMACY, MYSORE Feb 1, 2014 1
  • 2. CONTENTS  INTRODUCTION  EPIDEMIOLOGY  AETIOLOGY  PATHOGENESIS  DIAGNOSIS  CLINICAL FEATURES  TREATMENT Feb 1, 2014 2
  • 3. INTRODUCTION • Psoriasis is a chronic inflammatory condition that may affect the skin and joints Feb 1, 2014 3
  • 5. EPIDEMIOLOGY • Psoriasis affects both sexes equally • Can occur at any age, although it most commonly appears for the first time between the ages of 15 and 25 years Feb 1, 2014 5
  • 9. PATHOGENESIS •Many changes occur in the skin •Epidermis – Acanthosis, Parakeratosis •Dermis – capillaries are dilated, twisted, closer to the surface of the skin Feb 1, 2014 9
  • 10. • Large number of inflammatory cells are present in all layers of the skingranulocytes are predominant and form micro-abscessess in the epidermis • Langerhan cells and lymphocytes are also increased • Main abnormality is epidermal cell turn over Feb 1, 2014 the increased 10
  • 11. Two hypothesis: 1. Hyperproliferation may be due to immunological response. Cytokines released by lymphocytes and langerhan cells may further stimulate the inflammatory cells which cause epidermal cell turn over at an increased rate Feb 1, 2014 11
  • 12. 2. Epithelial cells themselves produce cytokines which promote proliferation of epithelial cells and attract lymphocytes Feb 1, 2014 12
  • 14. DIAGNOSIS • A diagnosis of psoriasis is usually based on the appearance of the skin • There are no special blood tests or diagnostic procedures • Skin biopsy, may be needed to rule out other disorders and to confirm the diagnosis • Skin from a biopsy will show clubbed rete pegs, if positive for psoriasis • Another sign of psoriasis is that when the plaques are scraped, one can see pinpoint bleeding from the skin below  Feb 1, 2014 14
  • 15. Rete pegs are the epithelial extensions that project into the underlying connective tissue Feb 1, 2014 15
  • 17. CLINICAL FEATURES • Typical psoriatic lesion is red, scaly, sharply demarcated plaque Feb 1, 2014 17
  • 18. • It can be on any size and can affect any part of the body Feb 1, 2014 18
  • 19. • The scales are silvery and easily scraped off revealing tiny bleed points • Psoriasis is not typically itchy, but it can cause itching when severely inflammed and rapidly spreading to the palms and soles Feb 1, 2014 19
  • 20. • Different patterns of psoriasis are: 1. 2. 3. 4. 5. 6. 7. Guttate psoriasis Chronic plaque psoriasis Psoriasis of scalp Psoriasis of nails Psoriasis of palms and soles Flexural psoriasis Erythrodermic and generalized pustular psoriasis 8. Psoriatic arthropathy Feb 1, 2014 20
  • 21. GUTTATE PSORIASIS Multiple small plaques are seen all over the body Mainly seen in children after streptococcal sore throat Self limiting after a few weeks Feb 1, 2014 21
  • 22. CHRONIC PLAQUE PSORIASIS Medium and large plaques occur on the limb and trunk Very persistent Feb 1, 2014 22
  • 23. PSORIASIS OF THE SCALP May occur as demarcated plaques or may involve the entire scalp extending to the hairline Scales are white, thick and chalky Hair loss will occur if the scalp is thickly scaled Recover if the scales are cleared and kept under control Feb 1, 2014 23
  • 24. PSORIASIS OF THE NAILS Pitting, onycholysis and hyperkeratosis under the nail Very resistant Feb 1, 2014 24
  • 25. PSORIASIS OF THE PALMS AN SOLES Sharp demarcation of the involved areas Affected areas are inflammed and scaly and may contain sterile pustules of large pin head size. These pustules dry up and form brown macules Affected skin becomes hyperatotic and fissuring Secondary infection with itching and pain are common Feb 1, 2014 25
  • 26. FLEXURAL PSORIASIS Psoriasis occurs in the axillae, submammary areas, groin and genitalia Demarcation is present, but the affected areas are glazy rather than scaly and is bright red in color Feb 1, 2014 26
  • 27. ERYTHRODERMIC AND GENERALIZED PUSTULAR PSORIASIS Severe and life threatening condition Uncommon Whole skin surface is involved and highly inflammed and the patient is sick Pustules are sterile and coalesce to form sheets of pus Feb 1, 2014 27
  • 28. PSORIATIC ARTHROPATHY Occurs in 5% of the patients with psoriasis Similar to RA, but RF is negative Different patterns: 1. 2. 3. Feb 1, 2014 Distal Arthritis Large Joint Involvement Spodilitis/ Sacroiliitis 28
  • 30. TREATMENT Aimed at controlling the current attack and not curing, and does not influence future progress of the disease TOPICAL THERAPY 1. Emolients 2. Topical Steroids 3. Dithranol 4. Coal Tar 5. Salicylic Acid 6. Vitamin D Analogues 7. UVB Feb 1, 2014 SYSTEMIC THERAPY 1. PUVA 2. Cytotoxic Drugs 3. Immunosuppressant Drugs 4. Acitretin 5. Photodynamic Therapy 6. Systemic Steroids 30
  • 31. TOPICAL THERAPY 1. EMOLIENTS • Used alone in very mild cases • Used along with other therapies for moderate to severe disease Feb 1, 2014 31
  • 32. 2. TOPICAL STEROIDS • Most useful for acutely inflammed psoriasis • Mild steroids are used on face and flexures • Potent steroids are used on hands and feet; in combination with Clioquinol or Salicylic acid • Aq. and alcoholic solutions cause stinging and burning, thus usually ointments, creams and mousse are prefered • Use of potent steroids on large areas of psoriasis may cause rebound flare when discontinued Feb 1, 2014 32
  • 34. 4. COAL TAR • Used in combination with emolients, topical steroids, and salicylic acid • Used for guttate psoriasis, psoriasis of the scalp, and localized pustular psoriasis of the palms and soles • Efficiency of coal tar is enhanced when used with UVB Feb 1, 2014 34
  • 35. 5. SALICYLIC ACID • Useful to remove the scales • Used in preparation for other treatment Feb 1, 2014 35
  • 36. 6. VITAMIN D ANALOGUES • Efficacy of topical vit D analogues is enhanced when used in combination with topical steroids and UVB • Calciptriol & Tacalcitol • Calciptriol is more effective than coal tar and dithranol. It cannot be used on face. • Tacalcitol is used for once daily treatment of chronic plaque psoriasis. It can be used on the face Feb 1, 2014 36
  • 37. 7. UVB • Short wavelength ultraviolet light is used in combination with coal tar or dithranol • Narrow band UVB is more effective Feb 1, 2014 37
  • 38. SYSTEMIC THERAPY 1. PUVA • Used for the treatment of moderate to severe chronic plaque psoriasis • PSORALENS: drugs that are activated by UVA (320400nm), to interfere with the DNA synthesis and reduce the epidermal cell turn over • Eg: 5-methoxy psoralen & 8-methoxy psoralen • Can be administered orally or it can be applied topically Feb 1, 2014 38
  • 39. The time of exposure is calculated based upon the previous light testing and the time interval is increased if tolerated by the patient as the treatment progresses Treatment is given twice weekly for 6 weeks Unless the disease is severe, maintenance dose is avoided to minimize the long term side effects Adverse effects: Nausea, pruritis, dry skin, aging of the skin, melanoma and non-melanoma skin cancer Feb 1, 2014 39
  • 40. 2. CYTOTOXIC DRUGS • Methotrexate & hydroxycarbamide • METHOTREXATE • Most effective in the treatment of psoriatic arthritis • Test dose- 2.5 mg • Then 30 mg weekly • Side effects: nausea, fatigue, GI bleeding Feb 1, 2014 40
  • 41. • HYDROXYCARBAMIDE • It should be used continuously as relapse will occur when the drug is stopped • Causes bone marrow depression Feb 1, 2014 41
  • 42. 3. IMMUNOSUPPRESSANT DRUGS • CICLOSPORIN • Severe psoriasis • Dose is 2-5 mg/kg/day • Relapse may occur when the drug is stopped but intermittent therapy is preferred to maintenance therapy • Avoid sun over exposure, PUVA & UVB therapy Feb 1, 2014 42
  • 43. 4. ACITRETIN • Used for severe resistant psoriasis, acute pustular psoriasis, and palmoplantar psoriasis • Has teratogenic effect • Re-PUVA therapy: acitretin + PUVA • It causes bone maturation abnormality, LFT and serum lipid levels • Causes dry skin and hair loss Feb 1, 2014 43
  • 44. 5. PHOTODYNAMIC THERAPY • 5-aminolaevullinic acid (ALA) causes local accumulation of proto porphyrin 9 which is activated by irradiation with visible light and causes tissue destruction • Used for localized plaque psoriasis • Causes burning sensation at the site of treatment Feb 1, 2014 44
  • 45. 6. SYSTEMIC STEROIDS • Not commonly used • May be used for the management of life threatening erythroderma • Systemic steroids or their withdrawal may itself provoke acute generalised pustular psoriasis Feb 1, 2014 45